SEARCH

SEARCH BY CITATION

References

  • Aichele, P., Brduscha-Riem, K., Zinkernagel, R.M., Hengartner, H., Pircher, H. (1995) T cell priming versus T cell tolerance induced by synthetic peptides. Journal of Experimental Medicine, 182, 261266.
  • Banchereau, J. & Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature, 392, 245252.DOI: 10.1038/32588
  • Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annual Review of Immunology, 18, 767811.
  • Bender, A., Sapp, M., Schuler, G., Steinman, R.M., Bhardwaj, N. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. Journal of Immunological Methods, 196, 121135.DOI: 10.1016/0022-1759(96)00079-8
  • Boon, T., Gajewski, T.F., Coulie, P.G. (1995) From defined human tumor antigens to effective immunization? Immunology Today, 16, 334336.
  • Caux, C., Liu, Y.-J., Banchereau, J. (1995) Recent advances in the study of dendritic cells and follicular dendritic cells. Immunology Today, 16, 25.
  • Cella, M.F., Sallusto, F., Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology, 9, 1016.
  • Chen, B.-G., Shi, Y., Smith, J.D., Choi, D., Geiger, J.D., Mule, R.J. (1998) The role of tumor necrosis factor α in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro. Blood, 91, 46524661.
  • Duperrier, K., Eljaafari, A., Dezutter-Dambuyant, C., Bardin, C., Jacquet, C., Yoneda, K., Schmitt, D., Gebuhrer, L., Rigal, D. (2000) Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. Journal of Immunological Methods, 238, 119131.DOI: 10.1016/s0022-1759(00)00147-2
  • Gong, J., Chen, D., Kashiwada, M., Li, Y., Chen, L., Takeuchi, H., Qu, H., Rowse, G.J., Gendler, S.J., Kufe, D. (1998) Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proceedings of the National Academy of Science of the United States of America, 95, 62796283.
  • Hart, D.N.J. (1997) Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood, 90, 32453287.
  • Houghton, A.N. (1994) Cancer antigens: Immune recognition of self and altered self. Journal of Experimental Medicine, 180, 14.
  • Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G., Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine, 2, 5258.
  • Ikuta, Y., Okugawa, T., Furugen, R., Nagata, Y., Takahashi, Y., Wang, L., Ikeda, H., Watanabe, M., Imai, S., Shiku, H. (2000) A HER2/neu-derived peptide, a Kd-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8+ cytotoxic T lymphocytes. International Journal of Cancer, 87, 553558.DOI: 10.1002/1097-0215(20000815)87:4<553::aid-ijc15>3.0.co;2-8
  • Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., Enk, A.H. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. European Journal of Immunology, 27, 31353142.
  • Lim, S.H. & Bailey-Wood, R. (1999) Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. International Journal of Cancer, 83, 215222.DOI: 10.1002/(sici)1097-0215(19991008)83:2<215::aid-ijc12>3.3.co;2-h
  • Mackensen, A., Herbst, B., Chen, J.-L., Köhler, G., Noppen, C., Herr, W., Spagnolf, G.C., Cerundolo, V., Lindemann, A. (2000) Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. International Journal of Cancer, 86, 385392.DOI: 10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t
  • Mitani, H., Katayama, N., Araki, H., Ohishi, K., Kobayashi, K., Suzuki, H., Nishii, K., Masuya, M., Yasukawa, K., Minami, N., Shiku, H. (2000) Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. British Journal of Haematology, 109, 288295.DOI: 10.1046/j.1365-2141.2000.02020.x
  • Mitterer, M., Mair, W., Gatti, D., Sheldon, J., Vachula, M., Coser, P., Schultz, T.F. (1998) Dendritic cells derived from bone marrow and CD34+ selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genome. British Journal of Haematology, 102, 13381340.
  • Morse, M.A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S., Schlom, J., Ryback, M.-E., Lyerly, H.K. (1999) A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clinical Cancer Research, 5, 13311338.
  • Murphy, G., Tjoa, B., Ragde, H., Kenny, G., Boynton, A. (1996) Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate, 29, 371380.DOI: 10.1002/(sici)1097-0045(199612)29:6<371::aid-pros5>3.3.co;2-3
  • Nagata, Y., Furugen, R., Hiasa, A., Ikeda, H., Ohta, N., Furukawa, K., Nakamura, H., Kurukawa, K., Kanematsu, T., Shiku, H. (1997) Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. Journal of Immunology, 159, 13361343.
  • Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Medicine, 3, 328332.
  • Okugawa, T., Ikuta, Y., Takahashi, Y., Obata, H., Tanida, K., Watanabe, M., Imai, S., Furugen, R., Nagata, Y., Toyoda, N., Shiku, H. (2000) A novel human HER2-derived peptide homologous to the mouse Kd-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals. European Journal of Immunology, 30, 33383346.DOI: 10.1002/1521-4141(200011)30:11<3338::aid-immu3338>3.0.co;2-3
  • Pardoll, D.M. (1998) Cancer vaccines. Nature Medicine, 4, 525531.
  • Pietschmann, P., Stöckl, J., Draxler, S., Majdic, O., Knapp, W. (2000) Functional and phenotyipic characteristics of dendritic cells generated in human plasma supplemented medium. Scandinavian Journal of Immunology, 51, 377383.DOI: 10.1046/j.1365-3083.2000.00690.x
  • Percelli, S.A. & Modlin, R.L. (1999) THE CD1 SYSTEMS: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annual Review of Immunology, 17, 297329.
  • Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G., Levy, R. (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: a feasibility study. Blood, 93, 24112419.
  • Romani, N., Reider, D., Heuer, M., Ebner, S., Kämpgen, E., Eibl, B., Niederwieser, D., Schuler, G. (1996) Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. Journal of Immunological Methods, 196, 137151.DOI: 10.1016/0022-1759(96)00078-6
  • Siena, S., Nicola, M.D., Bregni, M., Mortarini, R., Anichini, A., Lombardi, L., Ravagnani, F., Parmiani, G., Gianni, A.M. (1995) Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Experimental Hematology, 23, 14631471.
  • Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annual Review of Immunology, 9, 271296.
  • Sugita, M. & Brenner, M.B. (2000) T lymphocytes recognition of human group 1, CD1 molecules: Implications for innate and acquired immunity. Immunology, 12, 511516.
  • Tarte, K., Fiol, G., Rossi, J.-F., Klein, B. (2000) Extensive characterization of dendritic cells generated in serum-free conditions: Regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro. Leukemia, 14, 21822192.
  • Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Maczek, C., Schreiner, D., Von Den Driesch, P., Bröcker, E.B., Steinman, R.M., Enk, A., Kämpgen, E., Schuler, G. (1999) Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. Journal of Experimental Medicine, 190, 16691678.
  • Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V., Bohlen, H. (2000) Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: Immunological and clinical aspects. British Journal of Haematology, 108, 805816.DOI: 10.1046/j.1365-2141.2000.01958.x
  • Toes, R.E., Blom, R.J., Offringa, R., Kast, W.M., Melief, C.J.M. (1996) Enhanced tumor growth after peptide vaccination: Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. Journal of Immunology, 156, 39113918.
  • Toes, R.E.M., Van Der Voort, E.I.H., Schoenberger, S.P., Drijfhout, J.W., Van Bloois, L., Storm, G., Kast, W.M., Offringa, R., Melief, C.J.M. (1998) Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. Journal of Immunology, 160, 44494456.
  • Van den Eynde, B.J. & Van Der Bruggen, P. (1997) T cell defined tumor antigens. Current Opinion in Immunology, 9, 684693.